New knowledge on the pharmacology of dopamine stabilizers
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease pridopidine or dopamine stabiliser ACR16 might operate via previously unknown mechanisms of action. Researchers have ...
Feb 24, 2012
0
0